Med-tech Companies to Face New Pressures in China

Dow Jones

07/15

0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. "This development raises further questions about the longer-term revenue and profitability potential of the Chinese market" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

July 15, 2026 03:51 ET (07:51 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2651045891"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2651045891\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2651045891?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 15:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651045891","market":"fut","top_or_hot":-1,"title":"Med-tech Companies to Face New Pressures in China","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 15, 2026 03:51 ET (07:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Med-tech Companies to Face New Pressures in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMed-tech Companies to Face New Pressures in China\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-07-15 15:51</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 15, 2026 03:51 ET (07:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHG","symbol_name":"飛利浦","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2651045891","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651045891","pubTimestamp":1784101860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%.  Dow Jones NewswiresJuly 15, 2026 03:51 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PHG":"飞利浦","BK4588":"碎股","BK4082":"医疗保健设备","BK4585":"ETF&股票定投概念"},"translate_title":"医疗科技公司在中国面临新压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHG":0.9},"content_text":"0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 15, 2026 03:51 ET (07:51 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}